Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients.
Phase of Trial: Phase IV
Latest Information Update: 30 Jul 2014
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypertension; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms RESERVE
- 10 Jun 2017 Biomarkers information updated
- 08 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2012 Planned end date changed from 1 Jun 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.